IVA
Inventiva S.A.
Price Chart
Latest Quote
$4.62
+0.10 (+2.21%)
Current Price
| Previous Close | $4.52 |
| Open | $4.57 |
| Day High | $4.68 |
| Day Low | $4.49 |
| Volume | 862,210 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 236.22M |
| Total Debt | $264.27M |
| Cash Equivalents | $114.27M |
| Revenue | $7.74M |
| Net Income | $-405.33M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.09B |
| EPS (TTM) | $-2.16 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.09B |
| Sales | $7.74M |
| Income | $-405.33M |
| Book/sh | $-0.17 |
| Cash/sh | $0.42 |
| Employees | 69 |
Financial Ratios
| Quick Ratio | 1.41 |
| Current Ratio | 3.16 |
Returns & Margins
| ROA | -45.08% |
| Gross Margin | 99.68% |
| Operating Margin | -6710.69% |
Ownership
| Institutional Ownership | 26.12% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.41 |
| P/S | 161.42 |
| P/B | -27.22 |
Analyst Data
| Recommendation | none |
| Target Price | $15.13 |
Technical Indicators
| SMA20 | $4.00 |
| SMA50 | $4.43 |
| SMA200 | $5.12 |
| RSI | 77.38 |
| ATR | 0.3129 |
| Shares Float | 160.69M |
| Short Float | 0.64% |
| Short Ratio | 1.12 |
| Volatility | 0.89 |
| Rel Volume | 0.51 |
Performance History
| Week | +7.44% |
| Month | +29.05% |
| Quarter | -17.94% |
| 6 Months | -22.74% |
| YTD | -2.94% |
| Year | +39.16% |
| 3 Years | +9.74% |
| 5 Years | -67.00% |
| 10 Years | -65.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $4.62 | 862,400 |
| 2026-07-16 | $4.52 | 869,700 |
| 2026-07-15 | $4.47 | 985,000 |
| 2026-07-14 | $4.40 | 1,294,800 |
| 2026-07-13 | $4.30 | 734,800 |
| 2026-07-10 | $4.30 | 582,500 |
| 2026-07-09 | $4.53 | 1,782,100 |
| 2026-07-08 | $4.39 | 3,403,300 |
| 2026-07-07 | $4.56 | 3,292,100 |
| 2026-07-06 | $3.90 | 3,001,000 |
| 2026-07-02 | $3.91 | 1,830,200 |
| 2026-07-01 | $3.69 | 1,724,700 |
| 2026-06-30 | $3.78 | 2,095,700 |
| 2026-06-29 | $3.55 | 1,190,100 |
| 2026-06-26 | $3.41 | 1,335,200 |
| 2026-06-25 | $3.50 | 2,121,100 |
| 2026-06-24 | $3.46 | 1,094,400 |
| 2026-06-23 | $3.71 | 1,527,400 |
| 2026-06-22 | $3.51 | 862,500 |
| 2026-06-18 | $3.57 | 3,549,800 |
About Inventiva S.A.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-Ã, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
đ° Latest News
Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring
Insider Monkey âĸ 2026-07-15T08:53:08Z
Inventiva (ENXTPA:IVA) Puts Its MASH Narrative To The Test After A Recent Rebound
Simply Wall St. âĸ 2026-07-12T13:08:21Z
European Equities Traded in the US as American Depositary Receipts Rise Thursday
MT Newswires âĸ 2026-07-09T15:10:58ZInventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside
Insider Monkey âĸ 2026-06-30T16:34:52Z
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Inventiva (IVA)
Zacks âĸ 2026-06-29T13:35:07Z
Down 31.8% in 4 Weeks, Here's Why Inventiva (IVA) Looks Ripe for a Turnaround
Zacks âĸ 2026-06-11T13:35:02Z
Assessing Inventiva (ENXTPA:IVA) Valuation As Losses Deepen And MASH Trial Progresses
Simply Wall St. âĸ 2026-05-21T06:11:30Z
How The Inventiva (ENXTPA:IVA) Story Is Shifting As Analyst Views Grow More Divided
Simply Wall St. âĸ 2026-05-20T00:21:23Z
Inventiva Builds Up Leadership Team Ahead of Potential Commercialization
Exec Edge âĸ 2026-04-22T22:03:19Z
How The Inventiva (ENXTPA:IVA) Story Is Shifting With Lanifibranor And Analyst Revisions
Simply Wall St. âĸ 2026-04-07T04:32:40Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $5,129,291 | $10,524,028 | $19,996,568 | $13,934,783 |
| Operating Revenue | $5,129,291 | $10,524,028 | $19,996,568 | $13,934,783 |
| Expenses | ||||
| Interest Expense | $38,402,747 | $13,933,639 | $5,924,485 | $808,925 |
| Total Expenses | $157,169,342 | $118,062,933 | $137,462,247 | $78,988,561 |
| Other Income Expense | $-218,022,891 | $-90,209,385 | $-3,340,961 | $3,348,970 |
| Net Non Operating Interest Income Expense | $-35,100,688 | $-12,664,760 | $-4,843,250 | $-416,476 |
| Total Other Finance Cost | $67,506 | $38,902 | $52,632 | $53,776 |
| Interest Expense Non Operating | $38,402,747 | $13,933,639 | $5,924,485 | $808,925 |
| Operating Expense | $157,169,342 | $118,062,933 | $137,462,247 | $78,988,561 |
| Other Operating Expenses | $-4,372,998 | $-6,276,888 | $-6,505,721 | $-7,927,918 |
| Selling And Marketing Expense | $5,538,902 | $1,929,062 | $2,008,009 | $2,705,950 |
| General And Administrative Expense | $56,122,428 | $17,635,012 | $15,848,971 | $14,772,312 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Net Interest Income | $-35,100,688 | $-12,664,760 | $-4,843,250 | $-416,476 |
| Interest Income | $3,369,565 | $1,307,780 | $1,133,867 | $446,224 |
| Normalized Income | $-241,975,409 | $-143,380,440 | $-125,568,940 | $-65,445,361 |
| Net Income From Continuing And Discontinued Operation | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Total Operating Income As Reported | $-161,342,111 | $-111,622,430 | $-117,516,022 | $-65,343,252 |
| Net Income Common Stockholders | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Net Income | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Net Income Including Noncontrolling Interests | $-405,188,801 | $-210,771,174 | $-126,344,398 | $-62,098,400 |
| Net Income Continuous Operations | $-405,188,801 | $-210,771,174 | $-126,344,398 | $-62,098,400 |
| Pretax Income | $-405,163,630 | $-210,413,051 | $-125,649,890 | $-62,121,284 |
| Special Income Charges | $-9,300,916 | $-4,083,524 | $-50,343 | $-148,741 |
| Earnings From Equity Interest | $-400,458 | $-358,124 | $-2,305,492 | $0 |
| Interest Income Non Operating | $3,369,565 | $1,307,780 | $1,133,867 | $446,224 |
| Operating Income | $-152,040,051 | $-107,538,905 | $-117,465,679 | $-65,053,778 |
| Depreciation Amortization Depletion Income Statement | $289,474 | $794,050 | $239,130 | $251,716 |
| Depreciation And Amortization In Income Statement | $289,474 | $794,050 | $239,130 | $251,716 |
| Per Share | ||||
| Diluted EPS | $-2.17 | $-3.52 | $-2.78 | $-1.50 |
| Basic EPS | $-2.17 | $-3.52 | $-2.78 | $-1.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $-54,405,608 | $-22,462,815 | $-258,867 | $2,009 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-145,450,806 | $-100,680,782 | $-115,716,251 | $-62,718,538 |
| Total Unusual Items | $-217,622,433 | $-89,851,262 | $-1,035,469 | $3,348,970 |
| Total Unusual Items Excluding Goodwill | $-217,622,433 | $-89,851,262 | $-1,035,469 | $3,348,970 |
| Reconciled Depreciation | $3,687,643 | $5,947,369 | $2,973,684 | $1,942,792 |
| EBITDA (Bullshit earnings) | $-363,073,239 | $-190,532,043 | $-116,751,720 | $-59,369,567 |
| EBIT | $-366,760,882 | $-196,479,412 | $-119,725,405 | $-61,312,359 |
| Diluted Average Shares | $213,259,070 | $68,396,685 | $51,889,932 | $47,425,324 |
| Basic Average Shares | $213,259,070 | $68,396,685 | $51,889,932 | $47,425,324 |
| Diluted NI Availto Com Stockholders | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Tax Provision | $25,172 | $358,124 | $694,508 | $-22,883 |
| Gain On Sale Of Ppe | $326,087 | $171,625 | $0 | $-10,297 |
| Restructuring And Mergern Acquisition | $9,627,003 | $4,255,149 | $50,343 | $138,444 |
| Gain On Sale Of Security | $-208,321,518 | $-85,767,738 | $-985,126 | $3,497,712 |
| Research And Development | $99,591,537 | $103,981,697 | $125,871,858 | $69,186,501 |
| Selling General And Administration | $61,661,329 | $19,564,074 | $17,856,980 | $17,478,261 |
| Other Gand A | $12,446,225 | $10,724,257 | $10,165,904 | $9,986,270 |
| Insurance And Claims | $1,772,311 | $0 | $0 | - |
| Salaries And Wages | $41,903,892 | $6,910,755 | $5,683,067 | $4,786,041 |
| Write Off | - | $425,629 | $0 | $0 |
| Impairment Of Capital Assets | - | $2,044,622 | $0 | $0 |
| Other Taxes | - | - | $0 | $0 |
| Provision For Doubtful Accounts | - | - | $0 | $0 |
Fetched: 2026-07-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-32,843,251 | $-122,075,519 | $-37,268,880 | $51,382,153 |
| Total Assets | $285,481,703 | $136,117,854 | $79,589,248 | $132,727,693 |
| Total Non Current Assets | $5,771,167 | $8,530,893 | $24,455,378 | $11,009,154 |
| Non Current Prepaid Assets | $1,329,519 | $1,197,941 | $11,504,577 | $1,834,096 |
| Non Current Deferred Assets | $218,535 | $248,284 | $257,437 | $0 |
| Non Current Deferred Taxes Assets | $218,535 | $248,284 | $257,437 | $0 |
| Goodwill And Other Intangible Assets | $209,382 | $54,920 | $620,137 | $649,886 |
| Other Intangible Assets | $209,382 | $54,920 | $620,137 | $649,886 |
| Current Assets | $279,712,824 | $127,586,961 | $55,136,158 | $121,720,828 |
| Other Current Assets | $601,831 | $399,314 | $481,693 | $322,654 |
| Prepaid Assets | $4,521,739 | $2,794,050 | $5,327,231 | $9,840,961 |
| Inventory | $0 | $0 | $477,117 | $426,773 |
| Receivables | $10,435,927 | $13,909,611 | $17,971,397 | $10,689,932 |
| Other Receivables | $1,917,620 | $1,864,989 | $1,695,652 | $319,222 |
| Taxes Receivable | $6,211,671 | $11,437,071 | $11,919,909 | $10,370,710 |
| Accounts Receivable | $2,306,636 | $607,552 | $4,355,835 | $0 |
| Cash Cash Equivalents And Short Term Investments | $264,153,327 | $110,483,986 | $30,878,720 | $100,440,507 |
| Cash And Cash Equivalents | $113,629,295 | $110,483,986 | $30,798,628 | $99,241,422 |
| Cash Equivalents | $94,540,049 | $80,840,964 | $20,518,307 | $19,219,680 |
| Cash Financial | $19,089,246 | $29,643,022 | $10,280,321 | $80,021,742 |
| Investmentin Financial Assets | - | - | $10,297,483 | $800,915 |
| Non Current Accounts Receivable | - | - | - | $74,371 |
| Hedging Assets Current | - | - | - | $0 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $68,488,561 | $62,161,329 | $42,893,594 | $39,490,848 |
| Long Term Debt And Capital Lease Obligation | $31,522,884 | $55,447,370 | $36,820,367 | $32,796,340 |
| Long Term Debt | $30,681,923 | $53,004,579 | $31,938,216 | $29,097,255 |
| Current Debt And Capital Lease Obligation | $36,965,676 | $6,713,959 | $6,073,227 | $6,694,508 |
| Current Debt | $34,636,157 | $3,830,664 | $3,443,936 | $5,233,410 |
| Other Current Borrowings | $34,636,157 | $3,830,664 | $3,443,936 | $5,233,410 |
| Net Debt | - | - | $4,583,524 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $318,115,572 | $258,138,453 | $116,237,990 | $80,695,655 |
| Total Non Current Liabilities Net Minority Interest | $229,582,388 | $120,002,293 | $58,848,972 | $45,568,651 |
| Other Non Current Liabilities | $60,455,380 | $34,596,111 | $8,419,909 | $-2,288 |
| Derivative Product Liabilities | $136,596,115 | $27,820,367 | $11,744,852 | $11,299,772 |
| Non Current Deferred Liabilities | $144,165 | $122,426 | $80,092 | $62,929 |
| Current Liabilities | $88,533,184 | $138,136,160 | $57,389,018 | $35,127,004 |
| Other Current Liabilities | $1,144 | $83,982,840 | - | $-1,144 |
| Current Deferred Liabilities | $0 | $0 | $6,865 | $6,865 |
| Payables And Accrued Expenses | $50,340,963 | $47,439,361 | $51,308,926 | $28,426,774 |
| Payables | $38,053,777 | $45,447,370 | $49,546,912 | $26,893,594 |
| Other Payable | $6,260,870 | $3,358,124 | $2,164,760 | $2,148,741 |
| Total Tax Payable | $2,025,172 | $4,489,703 | $4,271,167 | $2,594,966 |
| Accounts Payable | $29,767,736 | $37,599,544 | $43,110,985 | $22,149,886 |
| Current Deferred Taxes Liabilities | - | - | $0 | $0 |
| Equity | ||||
| Common Stock Equity | $-32,633,868 | $-122,020,599 | $-36,648,743 | $52,032,038 |
| Total Equity Gross Minority Interest | $-32,633,868 | $-122,020,599 | $-36,648,743 | $52,032,038 |
| Stockholders Equity | $-32,633,868 | $-122,020,599 | $-36,648,743 | $52,032,038 |
| Gains Losses Not Affecting Retained Earnings | $-234,034,333 | $-197,426,780 | $-141,862,705 | $-85,305,495 |
| Other Equity Adjustments | $-234,762,022 | $-198,113,279 | $-142,544,627 | $-84,995,426 |
| Retained Earnings | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Long Term Equity Investment | $602,975 | $1,303,204 | $1,630,435 | $0 |
| Other | ||||
| Treasury Shares Number | $68,136 | $137,897 | $121,413 | - |
| Ordinary Shares Number | $221,026,812 | $109,453,540 | $59,629,072 | $48,208,433 |
| Share Issued | $221,094,948 | $109,591,437 | $59,750,485 | $48,208,433 |
| Tangible Book Value | $-32,843,251 | $-122,075,519 | $-37,268,880 | $51,382,153 |
| Invested Capital | $32,684,212 | $-65,185,357 | $-1,266,590 | $86,362,703 |
| Working Capital | $191,179,641 | $-10,549,199 | $-2,252,860 | $86,593,825 |
| Capital Lease Obligations | $3,170,481 | $5,326,087 | $7,511,442 | $5,160,183 |
| Total Capitalization | $-1,951,945 | $-69,016,021 | $-4,710,526 | $81,129,293 |
| Foreign Currency Translation Adjustments | $727,689 | $686,499 | $681,922 | $-310,069 |
| Additional Paid In Capital | $604,382,172 | $285,080,102 | $230,963,395 | $198,954,240 |
| Capital Stock | $2,210,526 | $1,094,966 | $596,110 | $481,693 |
| Common Stock | $2,210,526 | $1,094,966 | $596,110 | $481,693 |
| Employee Benefits | $863,844 | $2,016,018 | $1,783,753 | $1,411,899 |
| Non Current Pension And Other Postretirement Benefit Plans | $863,844 | $2,016,018 | $1,783,753 | $1,411,899 |
| Non Current Deferred Revenue | $144,165 | $122,426 | $80,092 | $62,929 |
| Long Term Capital Lease Obligation | $840,961 | $2,442,792 | $4,882,151 | $3,699,085 |
| Current Deferred Revenue | $0 | $0 | $6,865 | $6,865 |
| Current Capital Lease Obligation | $2,329,520 | $2,883,295 | $2,629,291 | $1,461,098 |
| Current Provisions | $1,225,401 | - | - | - |
| Current Accrued Expenses | $12,287,186 | $1,991,991 | $1,762,014 | $1,533,181 |
| Investments And Advances | $602,975 | $1,303,204 | $1,630,435 | $0 |
| Net PPE | $3,410,755 | $5,726,545 | $10,442,792 | $8,450,801 |
| Accumulated Depreciation | $-19,405,035 | $-17,383,296 | $-12,257,438 | $-9,789,474 |
| Gross PPE | $22,815,790 | $23,109,841 | $22,700,230 | $18,240,275 |
| Construction In Progress | $0 | $22,883 | $131,579 | $74,371 |
| Other Properties | $13,184,211 | $12,262,014 | $11,989,703 | $7,755,149 |
| Machinery Furniture Equipment | $5,465,675 | $6,657,895 | $6,411,900 | $6,243,707 |
| Buildings And Improvements | $3,969,108 | $3,970,252 | $3,970,252 | $3,970,252 |
| Land And Improvements | $196,796 | $196,796 | $196,796 | $196,796 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $150,524,033 | $0 | $80,092 | $1,199,085 |
| Available For Sale Securities | - | - | $10,297,483 | $800,915 |
| Other Inventories | - | - | $477,117 | $426,773 |
Fetched: 2026-07-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-120,287,190 | $-98,696,800 | $-93,997,715 | $-52,046,913 |
| Operating Activities | ||||
| Operating Cash Flow | $-120,004,581 | $-98,315,793 | $-93,379,866 | $-51,405,036 |
| Cash Flow From Continuing Operating Activities | $-120,006,869 | $-98,314,649 | $-93,379,866 | $-51,403,892 |
| Operating Gains Losses | $1,986,270 | $-592,677 | $2,645,309 | $392,449 |
| Investing Activities | ||||
| Capital Expenditure | $-282,609 | $-381,007 | $-617,849 | $-641,876 |
| Investing Cash Flow | $-152,386,733 | $10,005,721 | $-8,845,538 | $10,146,453 |
| Cash Flow From Continuing Investing Activities | $-152,385,589 | $10,005,721 | $-8,845,538 | $10,145,309 |
| Net Other Investing Changes | $-1,144 | - | - | $1,144 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $236,202,525 | $65,604,121 | $34,998,857 | $10,099,543 |
| Financing Cash Flow | $276,070,948 | $166,581,242 | $33,273,457 | $42,640,734 |
| Cash Flow From Continuing Financing Activities | $276,069,804 | $166,581,242 | $33,273,457 | $42,640,734 |
| Net Other Financing Charges | $-19,602,976 | $11,551,488 | $2,962,243 | $34,564,074 |
| Cash Dividends Paid | $0 | $0 | $0 | - |
| Net Common Stock Issuance | $236,202,525 | $65,604,121 | $34,998,857 | $10,099,543 |
| Common Stock Issuance | $236,202,525 | $65,604,121 | $34,998,857 | $10,099,543 |
| Other | ||||
| Repayment Of Debt | $-6,842,106 | $-5,711,671 | $-4,687,643 | $-2,022,883 |
| Issuance Of Debt | $0 | $28,508,010 | $0 | $34,564,074 |
| End Cash Position | $113,629,295 | $110,485,130 | $30,798,628 | $99,240,278 |
| Beginning Cash Position | $110,485,130 | $30,798,628 | $99,240,278 | $99,030,896 |
| Effect Of Exchange Rate Changes | $-535,469 | $1,415,332 | $509,153 | $-1,172,769 |
| Changes In Cash | $3,679,634 | $78,271,170 | $-68,950,803 | $1,382,151 |
| Interest Paid Cff | $-283,753 | $0 | $0 | - |
| Proceeds From Stock Option Exercised | $66,597,256 | $66,629,293 | $0 | $0 |
| Net Issuance Payments Of Debt | $-6,842,106 | $22,796,339 | $-4,687,643 | $32,541,191 |
| Net Long Term Debt Issuance | $-6,842,106 | $22,796,339 | $-4,687,643 | $32,541,191 |
| Long Term Debt Payments | $-6,842,106 | $-5,711,671 | $-4,687,643 | $-2,022,883 |
| Long Term Debt Issuance | $0 | $28,508,010 | $0 | $34,564,074 |
| Net Investment Purchase And Sale | $-152,102,980 | $10,386,728 | $-8,377,575 | $10,740,275 |
| Purchase Of Investment | $-152,102,980 | - | $-9,496,568 | $-1,144 |
| Net PPE Purchase And Sale | $-282,609 | $-381,007 | $-467,963 | $-594,966 |
| Sale Of PPE | $0 | $0 | $149,886 | $46,911 |
| Purchase Of PPE | $-282,609 | $-381,007 | $-617,849 | $-641,876 |
| Taxes Refund Paid | $5,623,570 | $6,101,831 | $5,972,540 | $4,065,218 |
| Change In Working Capital | $2,020,595 | $1,921,053 | $19,802,060 | $6,536,614 |
| Change In Other Working Capital | $-1,876,430 | $2,052,632 | $3,649,886 | $-1,927,918 |
| Change In Payables And Accrued Expense | $2,924,485 | $-3,819,222 | $22,885,584 | $4,044,623 |
| Change In Payable | $2,924,485 | $-3,819,222 | $22,885,584 | $4,044,623 |
| Change In Inventory | $0 | $477,117 | $-50,343 | $21,739 |
| Change In Receivables | $972,540 | $3,210,526 | $-6,683,067 | $4,398,169 |
| Other Non Cash Items | $243,870,718 | $100,471,399 | $2,455,378 | $1,237,986 |
| Stock Based Compensation | $30,628,148 | $4,096,110 | $4,541,190 | $2,537,758 |
| Deferred Tax | $-2,629,291 | $-5,491,991 | $-5,424,485 | $-6,019,451 |
| Deferred Income Tax | $-2,629,291 | $-5,491,991 | $-5,424,485 | $-6,019,451 |
| Depreciation Amortization Depletion | $3,687,643 | $5,947,369 | $2,973,684 | $1,942,792 |
| Depreciation And Amortization | $3,687,643 | $5,947,369 | $2,973,684 | $1,942,792 |
| Depreciation | $3,687,643 | $5,947,369 | $2,973,684 | $1,942,792 |
| Earnings Losses From Equity Investments | $400,458 | $173,913 | $2,305,492 | $0 |
| Net Foreign Currency Exchange Gain Loss | $1,558,352 | $-1,288,330 | $339,817 | $392,449 |
| Gain Loss On Sale Of PPE | $27,460 | $521,739 | $0 | $0 |
| Net Income From Continuing Operations | $-405,192,234 | $-210,768,886 | $-126,345,542 | $-62,098,400 |
| Sale Of Investment | - | $10,386,728 | $1,118,993 | $10,741,419 |
Fetched: 2026-07-17